KCNIP2 and Hyperglycemia: In addition, a study involving a rat model showed that maternal hyperglycemia can alter fetal cardiac function by down-regulating the expression of KCNIP2, the key regulatory factor mediating fetal cardiac electrophysiology and contractile function [15].